¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦37Â÷ ´ëÇÑ´ç´¢º´ÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦37Â÷ ´ëÇÑ´ç´¢º´ÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-02
±³À°ÀÏÀÚ : 2024-05-02
±³À°Àå¼Ò : â¿øÄÁº¥¼Ç¼¾ÅÍ

±³À°ÁÖÁ¦ : Á¦37Â÷ ´ëÇÑ´ç´¢º´ÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071  

À̸ÞÀÏ : diabetes@kams.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 1200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : °æ»ó³²µµ
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 250,000¿ø  

ºñ°í "Àü¹®ÀÇ: »çÀü ȸ¿ø 140,000¿ø, ÇöÀå ȸ¿ø, 200,000¿ø / »çÀü ºñȸ¿ø 200,000¿ø, ÇöÀå ºñȸ¿ø 250,000¿ø

Àü°øÀÇ ¹× ºñÀÇ»ç: »çÀü ȸ¿ø 70,000¿ø, ÇöÀå ȸ¿ø100,000¿ø / »çÀü ºñȸ¿ø 120,000¿ø, ÇöÀå ºñȸ¿ø 150,000¿ø" 


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 02ÀÏ Ã¢¿øÄÁº¥¼Ç¼¾ÅÍ Room 1 14:00~14:26 Reciprocal regulation of membrane localization by C2 and PH domains in response to intracellular Ca2+ concentrations ¿Àº´Ã¶(°¡ÃµÀÇ´ë ÀÇ¿¹°ú)

±³À°½Ã°£ 05¿ù 02ÀÏ Ã¢¿øÄÁº¥¼Ç¼¾ÅÍ Room 1 14:26~14:52 Role of ER-lysosome Ca2+ flux in lipid-induced inflammation and lipotoxicity À̸í½Ä(¼øõÇâÀÇ´ë ³»°ú)

±³À°½Ã°£ 05¿ù 02ÀÏ Ã¢¿øÄÁº¥¼Ç¼¾ÅÍ Room 1 14:52~15:20 The role of mitochondrial dysfunction in kidney diseases ÀÌÀαÔ(°æºÏÀÇ´ë ³»°ú)

±³À°½Ã°£ 05¿ù 02ÀÏ Ã¢¿øÄÁº¥¼Ç¼¾ÅÍ Room 2 15:20~15:40 Functional genomics: genome-wide CRISPR screening platform for decoding hormone-receptor pairs ÀÌÇå»ó(°í·Á´ë ºÐÀÚ»ý¸í°úÇаú)

±³À°½Ã°£ 05¿ù 02ÀÏ Ã¢¿øÄÁº¥¼Ç¼¾ÅÍ Room 2 15:40~16:00 scRNAseq and mouse genetics: hypothalamic function of IRX3 and IRX5, genetic determinants of human obesity ¼ÕÁ¶Àº(°æºÏ´ë ½ÄÇ°°øÇкÎ)

±³À°½Ã°£ 05¿ù 02ÀÏ Ã¢¿øÄÁº¥¼Ç¼¾ÅÍ Room 2 16:00~16:20 Metabolomics: dynamic regulation of muscle metabolism in obesity À±ÇýÁø(UNIST »ý¸í°úÇаú)

±³À°½Ã°£ 05¿ù 02ÀÏ Ã¢¿øÄÁº¥¼Ç¼¾ÅÍ Room 2 16:20~16:40 Protein design, amyloid protein and instrumental analysis ÃÖżö(°í·Á´ë ºÐÀÚ»ý¸í°úÇаú)

±³À°½Ã°£ 05¿ù 02ÀÏ Ã¢¿øÄÁº¥¼Ç¼¾ÅÍ Room 2 16:40~17:05 GLP-1 increases cognitive satiation via hypothalamic circuits in mice and humans ÃÖÇüÁø(¼­¿ïÀÇ´ë ÇغÎÇб³½Ç)

±³À°½Ã°£ 05¿ù 02ÀÏ Ã¢¿øÄÁº¥¼Ç¼¾ÅÍ Room 2 17:05~17:30 PG-102, next generation GLP-1/GLP-2 dual agonist for the treatment of metabolic diseases ±èÁ¾±Õ(ÇÁ·ÎÁ¨)

±³À°½Ã°£ 05¿ù 02ÀÏ Ã¢¿øÄÁº¥¼Ç¼¾ÅÍ Room 2 17:30~18:00 GLP-1À» Æ÷ÇÔÇÑ combination drugÀÇ NASH Ä¡·á È¿°ú (°¡Á¦) ÀüÇعÎ(Çѹ̾àÇ° R&D¼¾ÅÍ)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦37Â÷ ´ëÇÑ´ç´¢º´ÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-ÂøÈÄ°¢ÀÇ ¿øÀÎ, Áø´Ü, Ä¡·á¹ý : 2024-05-02
´ÙÀ½±Û (¿Â¶óÀÎ) Á¦5ȸ žÆÆò°¡¡¤°ü¸®À§¿øȸ ½ÉÆ÷Áö¾ö : 2024-04-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
345 ÀüºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ÀÎÁöÁßÀçÄ¡·áÀÇ ½ÇÁ¦¿Í Àü¸Á : 2018-09-04 0 549 2018-08-08
344 ºÎ»ê ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ 9¿ù Á¤±âÁý´ãȸ : 2018-09-04 0 496 2018-08-08
343 ¼­¿ï Á¦42ȸ ÇѸ²´ëÇб³°­³²¼º½Éº´¿ø ¾È°ú Áý´ãȸ : 2018-09-03 0 865 2018-08-08
342 ¼­¿ï ¼øõÇâ´ëÇм­¿ïº´¿ø Á¦42ȸ º¹ºÎÃÊÀ½ÆÄ ¹× ³»½Ã°æÃÊÀ½ÆÄ Áø´Ü ¿öÅ©¼ó : 2018-09-02 0 944 2018-08-08
341 ºÎ»ê Á¦21ȸ ´ëÇѳ»°úÇÐȸ ºÎ»ê°æ³²Áöȸ ¿¬¼ö°­Á : 2018-09-02 0 858 2018-08-08
340 ¼­¿ï 2018 ¼Ò¾Æ³»ºÐºñÇÐȸ ¿¬¼ö°­Á : 2018-09-02 0 1,191 2018-08-08
339 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4, 2ÀÏÂ÷) : 2018-09-02 0 602 2018-08-08
338 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Á¦23ȸ ´ç´¢º´ÀÇ ¿À´Ã°ú ³»ÀÏ : 2018-09-02 0 1,405 2018-08-08
337 ¼­¿ï ´ëÇÑû°¢ÇÐȸ 2018 Á¦19Â÷ º¸Ã»±â¿öÅ©¼¥ : 2018-09-02 0 729 2018-08-08
336 ºÎ»ê 2018³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãß°è Microsurgery Workshop : 2018-09-02 0 1,051 2018-08-08
335 ´ëÀü ´ëÇÑÀÓ»ó½Å°æ»ý¸®ÇÐȸ Á¦4ȸ ã¾Æ°¡´Â ¿öÅ©¼ó : 2018-09-02 0 1,017 2018-08-08
334 ´ë±¸ ´ë±¸±¤¿ª½ÃÀÇ»çȸ 2018 Á¾ÇÕÇмú´ëȸ : 2018-09-02 0 729 2018-08-08
333 ¼­¿ï 2018³â ´ëÇÑ¿Ü°úÀÇ»çȸ Ã߰迬¼ö°­Á : 2018-09-02 1 3,012 2018-08-08
332 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4,1ÀÏÂ÷) : 2018-09-01 0 433 2018-08-08
331 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4,1ÀÏÂ÷) : 2018-09-01 0 1,003 2018-08-08
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷